Future Tech II Acquisition Corp.
Status: Live Deal
U=S+W
W=S@11.5
IPO Proceeds, $M | $115.00M |
---|---|
IPO Date | Feb 16, 2022 |
CEO | Ray Chen |
Left Lead | EF Hutton |
IPO Cash in Trust | 102.0% |
SPAC Tenor | 12 + 3 + 3 + 6 + 9 + 9 |
IPO Sector |
Technology
Technology (excluding China) |
IPO Geography | Global |
Target Company | Longevity Biomedical |
Deal Announced | Sep 20, 2024 |
Deal Size, $M | TBD |
Deal Sector | Healthcare |
Deal Geography | US/Canada |
SEC Filings | www.sec.gov |
Approval Vote | TBD |
Amendment Vote | Nov 18, 2024 |
FTII
FTIIU
FTIIW
Price | $11.05 |
---|---|
Last closing price | $11.05 |
H/L, today | $11.01 / $11.06 |
H/L, 52-week | $10.08 / $12.12 |
Volume, today | 1,710 |
Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Future Tech II Acquisition Corp.:
- Structure and cap table
- 5 directors & officers
- 23 filings and events
- 4 underwriters
- 2 legal advisors
Structure
Sign in to view structure, cap table, and calendar of events.
Team
Name | Age | Title |
---|---|---|
Ray Chen | CEO, CFO and Director | |
Yuquan Wang | 50 | Director |
Neil Bush | 66 | Director |
Jeffrey Moseley | 67 | Director |
Jonathan McKeage | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
EF Hutton | BR | 945,000 | units |
Tiger Brokers | 6,050,000 | ||
US Tiger Securities | 3,000,000 | ||
Joseph Gunnar | 5,000 | ||
10,000,000 | units | ||
Up-Front UW fee | 2.00 | % | |
Deferred UW fee |
3.00 | % |
Sign in to view more advisor data.